FDA authorizes emergency use of convalescent plasma to treat COVID-19

The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on emergency use of convalescent plasma to treat COVID-19
December 4, 2025
14th Annual Discovery One-on-One Conference
September 10, 2025
3rd Annual Consumer One-on-One Conference
September 3, 2025
- September 4, 2025